COMMUNIQUÉS West-GlobeNewswire

Cancer Genetics Reports Second Quarter 2019 Financial Results and Provides Strategic Business Update
20/08/2019
RUTHERFORD, N.J., Aug. 20, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, today announced strategic, financial and [...]
Assertio Therapeutics to Present at the 17th Annual Morgan Stanley Global Healthcare Conference
20/08/2019
LAKE FOREST, Illinois, Aug. 20, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) today announced that members of senior management will participate at the 17 th Annual Morgan Stanley Global Healthcare [...]
Mersana Therapeutics Announces Initiation of Expansion Study of XMT-1536 in Patients with Platinum-Resistant Ovarian Cancer and Non-Small Cell Lung Cancer
20/08/2019
CAMBRIDGE, Mass., Aug. 20, 2019 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs [...]
Delcath Systems Closes $9.5 Million Private Placement
20/08/2019
Bringing total financial amount raised since July 2019 to $29.5M Cash runway past top-line results in 1H2020 with NDA submission anticipated by end of 2020 Recapitalization provides possible path to NASDAQ listing NEW [...]
AgraFlora Organics conclut un accord international exclusif visant la distribution de cosmétiques à base de CBD en Asie ce qui lui procure un accès immédiat à la Chine et à son marché du CBD estimé à 15 000 000 000 de dollars américains
20/08/2019
VANCOUVER, Colombie-Britannique, 20 août 2019 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (« AgraFlora » ou la « Société ») (CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF), une société internationale de [...]
Outlook Therapeutics Completes Patient Enrollment for NORSE 1 a Phase 3 Clinical Trial for ONS-5010 in Wet AMD
20/08/2019
Initial data expected to be announced in calendar Q3 2020 CRANBURY, N.J., Aug. 20, 2019 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (NASDAQ: OTLK) (the “Company”), a late clinical-stage biopharmaceutical company [...]
New Pilot Clinical Study Results Demonstrate that Addition of VIVUS’ Qsymia® to Gastric Sleeve Surgery Significantly Improves Weight Loss Compared with Surgery Alone
20/08/2019
-Data published in Surgery for Obesity and Related Diseases also show that patients in the Qsymia group lost more than twice as much weight during preoperative treatment compared with control group- CAMPBELL, Calif., [...]
Biogen and Invitae Announce Availability of Rapid Results in Genetic Testing Program for Spinal Muscular Atrophy (SMA) to Improve Speed of Diagnosis for Patients
20/08/2019
New SMA STAT genetic test reduces time to provide results from 21 to four days to aid in clinical care Early treatment of SMA has been shown to slow disease progression and improve or stabilize loss of motor function [...]
Axsome Therapeutics Appoints David Marek as Chief Commercial Officer
20/08/2019
NEW YORK, Aug. 20, 2019 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, [...]
MediPharm Labs Appoints Renowned Cannabis Researcher Dr. Landolt-Marticorena, MD, PhD, to its Science Advisory Committee
20/08/2019
TORONTO, Aug. 20, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”), a global leader in specialized, research-driven cannabis extraction, [...]
Tonix Pharmaceuticals Expands Preclinical Pipeline with Triple Reuptake Inhibitor, TNX-1600, for the Treatment of PTSD
20/08/2019
NEW YORK, Aug. 20, 2019 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today an exclusive agreement to in-license a [...]
Entera Bio Reports Second Quarter 2019 Financial Results and Provides Operating Update
20/08/2019
Phase 2 study for oral PTH in osteoporosis was initiated in June 2019; Data expected in 2020 Completed Part 2 of a Phase 2 PK/PD study in hypoparathyroidism patients. Results expected to be presented in Q3 2019. [...]
Avricore Health Corporate Update and Private Placement Extension
20/08/2019
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES VANCOUVER, British Columbia, Aug. 20, 2019 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) ("Avricore Health" or the " [...]
Medtronic Reports First Quarter Financial Results
20/08/2019
Revenue of $7.5 Billion Increased 1.5% Reported; Increased 3.5% Constant Currency GAAP Diluted EPS of $0.64; Non-GAAP Diluted EPS of $1.26 Company Raises FY20 EPS Guidance by 10 Cents DUBLIN, Aug. 20, 2019 (GLOBE [...]
Transactions in relation to share buyback program
20/08/2019
Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 1, 2019, in accordance with article 5 of Regulation (EU) no. 596/2014 of April 16, 2014 on [...]
Medcolcanna Signs Licensing and Profit-Sharing Agreement with Herbolea Biotech for Patent Pending Technology
20/08/2019
BOGOTÁ, Colombia, Aug. 20, 2019 (GLOBE NEWSWIRE) -- Medcolcanna Organics Inc . (TSX-V: MCCN) (“ Medcolcanna ” or the “ Company ”), a Canadian medical cannabis company with operations in Colombia, is pleased to announce [...]
Parallax Health Sciences Reports Second Quarter 2019 Financial Results
20/08/2019
Company Reduces Net Loss by 40% Over Prior Year Six Months Period SANTA MONICA, Calif., Aug. 20, 2019 (GLOBE NEWSWIRE) -- Parallax Health Sciences, Inc. (OTCQB: PRLX) (“Parallax”), an outcome-driven connected healthcare [...]
AB Science annonce le succès d'un placement privé
20/08/2019
AB SCIENCE REALISE AVEC SUCCES UN PLACEMENT PRIVE EUR 10,00 millions levés par un placement privé de 2.263.054 actions ordinaires nouvelles au prix de EUR 4,06 (assorties de bons de souscription d’actions donnant droit [...]
AgraFlora Organics Enters Into Exclusive Asian CBD Cosmetics Distribution Agreement; Achieves Immediate Access to China’s Projected US$15,000,000,000 CBD Marketplace
20/08/2019
VANCOUVER, British Columbia, Aug. 20, 2019 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (“ AgraFlora ” or the “ Company ”) ( CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF ), a growth oriented and diversified [...]

Pages